Flexion Therapeutics (Flexion Therapeutics) Change In Inventory : $-0.9 Mil (TTM As of Sep. 2021)

View and export this data going back to 2014. Start your Free Trial

What is Flexion Therapeutics Change In Inventory?

Flexion Therapeutics's change in inventory for the quarter that ended in Sep. 2021 was $-3.6 Mil. It means Flexion Therapeutics's inventory increased by $3.6 Mil from Jun. 2021 to Sep. 2021 .

Flexion Therapeutics's change in inventory for the fiscal year that ended in Dec. 2020 was $-0.9 Mil. It means Flexion Therapeutics's inventory increased by $0.9 Mil from Dec. 2019 to Dec. 2020 .

Flexion Therapeutics's Total Inventories for the quarter that ended in Sep. 2021 was $14.7 Mil.

Days Inventory indicates the number of days of goods in sales that a company has in the inventory. Flexion Therapeutics's Days Inventory for the quarter that ended in Sep. 2021 was 330.16.

Inventory Turnover measures how fast the company turns over its inventory within a year. Flexion Therapeutics's Inventory Turnover for the quarter that ended in Sep. 2021 was 0.28.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. Flexion Therapeutics's Inventory-to-Revenue for the quarter that ended in Sep. 2021 was 0.63.

Flexion Therapeutics Change In Inventory Historical Data

The historical data trend for Flexion Therapeutics's Change In Inventory can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Flexion Therapeutics Change In Inventory Chart

Flexion Therapeutics Annual Data

Trend

Dec11

Dec12

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Change In Inventory

Get a 7-Day Free Trial

-1.80

-5.24

-7.67

-0.92

Flexion Therapeutics Quarterly Data
	Dec16	Mar17	Jun17	Sep17	Dec17	Mar18	Jun18	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21
Change In Inventory	Get a 7-Day Free Trial															1.44	0.14	2.18	0.36	-3.58

Flexion Therapeutics Change In Inventory Calculation

Change In Inventory is the difference between last period's ending inventory and the current period's ending inventory.

Change In Inventory for the trailing twelve months (TTM) ended in Sep. 2021 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.9 Mil.

Flexion Therapeutics (NAS:FLXN) Change In Inventory Explanation

1. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Flexion Therapeutics's Days Inventory for the quarter that ended in is calculated as:

Days Inventory	=	Average Total Inventories	/	Cost of Goods Sold	*	Days in Period
	=	13.485	/	3.727	*	365 / 4
	=	330.16

2. Inventory Turnover measures how fast the company turns over its inventory within a year.

Flexion Therapeutics's Inventory Turnover for the quarter that ended in Sep. 2021 is calculated as

Inventory Turnover	=	Cost of Goods Sold	/	Average Total Inventories
	=	3.727	/	13.485
	=	0.28

3. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Flexion Therapeutics's Inventory to Revenue for the quarter that ended in Sep. 2021 is calculated as

Inventory-to-Revenue	=	Average Total Inventories	/	Revenue
	=	13.485	/	21.326
	=	0.63

Flexion Therapeutics Change In Inventory Related Terms

Thank you for viewing the detailed overview of Flexion Therapeutics's Change In Inventory provided by GuruFocus.com. Please click on the following links to see related term pages.

Flexion Therapeutics (Flexion Therapeutics) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Flexion Therapeutics Inc (NAS:FLXN) » Definitions » Change In Inventory

Comparable Companies

Traded in Other Exchanges

N/A

Address

10 Mall Road, Suite 301, Burlington, MA, USA, 01803

Website

http://www.flexiontherapeutics.com

Flexion Therapeutics Inc is a United States-based specialty pharmaceutical company. The company focuses on the development and commercialization of novel, local therapies. The company specializes in the treatment of patients with musculoskeletal conditions beginning with osteoarthritis. The products offered by company are zilretta which is used for enhancing the clinical effect of intra-articular corticosteroid treatment.

Executives

Mark S. Levine	officer: General Counsel	1601 TRAPELO ROAD, SUITE 284, WALTHAM MA 02451
Kerry Wentworth	officer: Chief Regulatory Officer	AGENUS INC., 3 FORBES ROAD, LEXINGTON MA 02421
Christina Willwerth	officer: Chief Strategy Officer	C/O FLEXION THERAPEUTICS, INC. 10 MALL ROAD, SUITE 301 BURLINGTON MA 01803
David Arkowitz	officer: Chief Financial Officer	C/O FLEXION THERAPEUTICS, INC., 10 MALL ROAD, SUITE 301, BURLINGTON MA 01803
Melissa Layman	officer: Chief Commercial Officer	C/O FLEXION THERAPEUTICS, INC. 10 MALL ROAD, STE. 301 BURLINGTON MA 01803
Scott Kelley	officer: Chief Medical Officer	C/O ASPECT MEDICAL SYSTEMS INC 141 NEEDHAM ST NEWTON MA 02464-1505
Elizabeth Kwo	director	C/O FLEXION THERAPEUTICS, INC., 10 MALL ROAD, SUITE 301, BURLINGTON MA 01803
Michael D. Clayman	director, officer: President and CEO	C/O FLEXION THERAPEUTICS, INC., 10 MALL ROAD, SUITE 301, BURLINGTON MA 01803
Alan Milinazzo	director	C/O ORTHOFIX INC, 10115 KINCEY AVENUE STE 250, HUNTERSVILLE NC 28078
Scott A Canute	director	FLEXION THERAPEUTICS, INC., 10 MALL ROAD, SUITE 301, BURLINGTON MA 01803
C Ann Merrifield	director
Heath Lukatch	director	326 BOLLAY DRIVE, GOLETA CA 93117
Samuel D Colella	director, 10 percent owner	ONE SANSOME STREET, SUITE 3630, SAN FRANCISCO CA 94104
Patrick J Mahaffy	director	C/O CLOVIS ONCOLOGY, INC., 5500 FLATIRON PARKWAY, SUITE 100, BOULDER CO 80301
Mark Stejbach	director	C/O TENGION, INC., 2900 POTSHOP LANE, SUITE 100, EAST NORRITON PA 19403